The Epidemiology of Lost Residual β-cell Function in Short Term Diabetic Children |
| |
Authors: | G. DAHLQUIST L. BLOM B. PERSSON M. WALLENSTEEN S. WALL |
| |
Affiliation: | Department of Pediatrics, Karolinska Institute, Sachs'Children's Hospital, Stockholm;Department of Pediatrics, Karolinska Institute, St Göran's Children's Hospital, Stockholm;Department of Epidemiology and Health Care Research, University of Umeå, Umeå, Sweden |
| |
Abstract: | ABSTRACT. Using the country-wide Swedish childhood diabetes register 526 children, who had had diabetes for 6–30 months were traced for measurements of 24-hour urinary C-peptide. Lost ft-cell function was defined as a 24-hour urinary C-peptide excretion per kg body weight less than 10% of the mean for healthy children (<0.025 nmol/kg). The estimated cumulative incidence of lost β-cell function was 0.64 at 30 months. The incidence of lost β-cell function did not differ by sex. Neither was there any significant variation in season at onset for cases with lost β-cell function. A significant age dependency was shown for the cumulative incidence of lost β-cell function with the highest incidence in the young age groups, i.e. a reversed age dependency compared to that of clinical onset. In contrast to the clinical onset of diabetes no significant geographical variation was found for lost β-cell function when comparing standardized morbidity ratios. The urinary C-peptide excretion was significantly correlated to age at onset but not to degree or duration of ketonuria at onset. It is concluded that there are striking differences when comparing the epidemiology of lost β-cell function to that of clinical onset in terms of age, sex, seasonal and geographical variations. The timing of clinical onset may thus partly be determined by factors different from those determining the rate of fall in β-cell function. |
| |
Keywords: | Type 1 diabetes β-cell function remission epidemiology |
|
|